COVID-19: Comparison between hydroxychloroquine and remdesivir is not right at this moment, says CSIR

New Delhi, May 05 (ANI): Council of Scientific and Industrial Research (CSIR) Director General Shekhar C Mande said that it is very difficult to compare the efficacy of hydroxychloroquine and remdesivir as of now. "Comparison between hydroxychloroquine and remdesivir is not right because we do not know the efficacy of both of them till now. Which one is better can only be ascertained after trials," said Dr Mande.